Results 131 to 140 of about 694,618 (154)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Gastric Cancer Peritoneal Metastases: Results from the Lithuanian PIPAC Program. [PDF]

Cancers (Basel)
Luksta M, Bausys A, Gendvilaite N, Bickaite K, Rackauskas R, Paskonis M, Luksaite-Lukste R, Ranceva A, Stulpinas R, Brasiuniene B, Baltruskeviciene E, Lachej N, Bausiene J, Poskus T, Bausys R, Tulyte S, Strupas K.   +16 more
europepmc   +1 more source

Efficacy and safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in ovarian cancer: a systematic review of current evidence. [PDF]

Arch Gynecol Obstet
Pavone M, Jochum F, Lecointre L, Bizzarri N, Taliento C, Restaino S, Vizzielli G, Fagotti A, Scambia G, Querleu D, Akladios C.   +10 more
europepmc   +1 more source

Efficacy of Hyperthermic Pressurized Intraperitoneal Aerosol Chemotherapy in an In Vitro Model Using a Human Gastric Cancer AGS Cell Line and an Abdominal Cavity Model. [PDF]

J Gastric Cancer
Min SH, Lee J, Yoo M, Hwang D, Lee E, Kang SH, Lee K, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH.   +11 more
europepmc   +1 more source

Modified scoring system for the quantitative assessment of histological regression in peritoneal carcinomatosis after pressurized intraperitoneal aerosol chemotherapy: A pilot study. [PDF]

Oncol Lett
Abbas M, Ramspott JP, Chourio Barboza DE, Pascher A, Wardelmann E, Sporn JC.   +5 more
europepmc   +1 more source

How to Implement Pressurized Intraperitoneal Aerosol Chemotherapy into a National Health System Scenario: A Single-Center Retrospective Analysis of Costs and Economic Sustainability at a High-Volume Italian Hospital. [PDF]

Cancers (Basel)
Aulicino M, Orsini C, D'Annibale G, Barberis L, Catania P, Abatini C, Attalla El Halabieh M, Ferracci F, Lodoli C, Santullo F, Pacelli F, Di Giorgio A.   +11 more
europepmc   +1 more source

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial). [PDF]

Ann Surg Oncol
Vizzielli G, Giudice MT, Nardelli F, Costantini B, Salutari V, Inzani FS, Zannoni GF, Chiantera V, Di Giorgio A, Pacelli F, Fagotti A, Scambia G.   +11 more
europepmc   +1 more source

Patient-reported outcomes during first-line palliative systemic therapy alternated with pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II). [PDF]

Surg Endosc
van de Vlasakker VCJ, Rauwerdink P, Rovers KPB, Wassenaar EC, Creemers GJ, Los M, Burger JWA, Nienhuijs SW, Kranenburg O, Wiezer MJ, Lurvink RJ, Boerma D, de Hingh IHJT.   +12 more
europepmc   +1 more source

Prospective, Single-Center Implementation and Response Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis [PDF]

Therapeutic Advances in Medical Oncology, 2018
Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a laparoscopy-guided administration of aerosolized chemotherapy. PIPAC seems to improve objective tumor response, survival and quality of life in patients with peritoneal metastasis.
Martin Graversen, Per Pfeiffer, Michael Bau Mortensen   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Cost-Effectiveness Analysis of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With Gastric Cancer and Peritoneal Metastasis

European Journal of Surgical Oncology, 2022
Marc A Reymond, Mohsen Yaghoubi, Mehdi Javanbakht   +2 more
exaly  

Assessment of Workplace Environmental Contamination and Occupational Exposure to Cisplatin and Doxorubicin Aerosols During Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy

European Journal of Surgical Oncology, 2021
Abdelkader Taibi, Mireille Canal-Raffin, Michel Druet-Cabanac   +2 more
exaly